DNA Biomed Solns (DNA) — Net Asset Quality Index
DNA Biomed Solns (DNA) has a Net Asset Quality Index of 98.2% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ILA100.00 Million minus total liabilities of ILA1.77 Million yields net assets of ILA98.23 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read how much debt does DNA Biomed Solns carry for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
DNA Biomed Solns Net Asset Quality Index Over Time (2005–2024)
This chart shows how DNA Biomed Solns's Net Asset Quality Index has evolved across 19 annual periods from 2005 to 2024. As of June 2025, the index stands at 98.2%, representing net assets of ILA98.23 Million against total assets of ILA100.00 Million ILA. For live market cap and overall valuation, see DNA Biomed Solns market capitalisation.
Annual Net Asset Quality Index for DNA Biomed Solns (2005–2024)
The table below presents the year-by-year Net Asset Quality Index for DNA Biomed Solns from 2005 to 2024, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check DNA Biomed Solns strategic capital allocation to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (ILA) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 97.3% | ILA101.47 Million | ILA104.28 Million | ILA2.81 Million | ▼ -0.9 pp |
| 2023 | 98.2% | ILA79.19 Million | ILA80.66 Million | ILA1.47 Million | ▲ +0.5 pp |
| 2022 | 97.7% | ILA80.11 Million | ILA81.99 Million | ILA1.88 Million | ▼ -1.8 pp |
| 2021 | 99.5% | ILA54.33 Million | ILA54.62 Million | ILA287.00K | ▲ +56.5 pp |
| 2020 | 43.0% | ILA7.95 Million | ILA18.49 Million | ILA10.54 Million | ▼ -33.7 pp |
| 2019 | 76.7% | ILA28.18 Million | ILA36.73 Million | ILA8.55 Million | ▼ -3.7 pp |
| 2018 | 80.4% | ILA64.90 Million | ILA80.72 Million | ILA15.81 Million | ▼ -8.1 pp |
| 2017 | 88.5% | ILA69.11 Million | ILA78.09 Million | ILA8.99 Million | ▲ +307.0 pp |
| 2016 | -218.5% | ILA-83.41 Million | ILA38.17 Million | ILA121.59 Million | ▼ -188.4 pp |
| 2015 | -30.1% | ILA-8.35 Million | ILA27.75 Million | ILA36.10 Million | ▲ +13.2 pp |
| 2014 | -43.3% | ILA-8.36 Million | ILA19.32 Million | ILA27.68 Million | ▼ -98.8 pp |
| 2013 | 55.6% | ILA11.49 Million | ILA20.68 Million | ILA9.19 Million | ▲ +1.2 pp |
| 2012 | 54.4% | ILA11.53 Million | ILA21.20 Million | ILA9.68 Million | ▼ -7.8 pp |
| 2011 | 62.1% | ILA10.45 Million | ILA16.82 Million | ILA6.37 Million | ▲ +56.1 pp |
| 2010 | 6.0% | ILA579.00K | ILA9.65 Million | ILA9.08 Million | ▲ +5398.6 pp |
| 2009 | -5392.6% | ILA-6.58 Million | ILA122.00K | ILA6.70 Million | ▼ -5333.5 pp |
| 2008 | -59.1% | ILA-3.00 Million | ILA5.07 Million | ILA8.07 Million | ▼ -0.8 pp |
| 2006 | -58.3% | ILA-1.99 Million | ILA3.42 Million | ILA5.41 Million | ▼ -108.6 pp |
| 2005 | 50.3% | ILA3.26 Million | ILA6.48 Million | ILA3.22 Million | — |